Automating library prep reduces hands-on time for customers using Pillar Biosciences oncoReveal® targeted oncology research panels
An advanced research workflow for fast, flexible detection of molecular residual disease during and following treatment
3 Healthcare Stocks That Fall Short
Former Labcorp Chairman and CEO brings deep healthcare, diagnostics, and clinical expertise to Illumina's Board
SAN DIEGO , May 19, 2026 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) today published its annual Corporate Responsibility (CR) Report. The report highlights the company's continued progress in expanding...
3 Reasons to Sell ILMN and 1 Stock to Buy Instead
1 Surging Stock on Our Buy List and 2 Facing Challenges
Prominent U.S. executives from Big Tech and Wall Street to agriculture and aerospace joined President Donald Trump on his trip to China
5 Revealing Analyst Questions From Illumina’s Q1 Earnings Call
3 Profitable Stocks We’re Skeptical Of